(Q34774333)

4 August 2017

1 reference

title

Controversies in lung transplantation: management of cytomegalovirus infections (English)

1 reference

4 August 2017

0 references

1 reference

cytomegaloviral disease

1 reference

Martin R Zamora

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

The Journal of Heart and Lung Transplantation

4 August 2017

published in

1 reference

4 August 2017

volume

21

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

841-849

1 reference

Infection in organ-transplant recipients

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Infection in solid organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

The cost impact of cytomegalovirus disease in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

The economic impact of cytomegalovirus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Cytomegalovirus infections in heart and heart-lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Lungs are a major organ site of cytomegalovirus latency and recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Comparison of the efficacy and cost effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Comparison of the efficacy and cost-effectiveness of pre-emptive therapy as directed by CMV antigenemia and prophylaxis with ganciclovir in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Prevention and treatment of cytomegalovirus disease in heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900435-7

7 January 2021

10.1016/S1053-2498(02)00435-7

Identifiers

DOI

1 reference

4 August 2017

1 reference